U7 small nuclear RNA (U7 snRNA)

U7 small nuclear RNA (U7 snRNA) is a highly conserved, noncoding RNA component of the U7 small nuclear ribonucleoprotein (U7 snRNP) complex, classified within the Sm-type U snRNP family[1][3][7]. Its primary, evolutionarily conserved function is the 3’ end processing of replication-dependent histone pre-mRNA during the S phase of the cell cycle[1][2][5][7]. U7 snRNA achieves this by binding to the histone downstream element (HDE) on the pre-mRNA, recruiting and directing the RNA-processing machinery for precise cleavage and maturation of histone transcripts[1][7]. Distinct from most mRNAs, histone mRNAs are not polyadenylated and require U7 snRNP-mediated processing[1][3][5]. Beyond its canonical role in histone mRNA maturation, U7 snRNA also represses the transcription of replication-dependent histone genes during cell cycle arrest by forming complexes with proteins such as hnRNP UL1[5]. It has a protective role in silencing certain deleterious genetic elements, including specific endogenous retrovirus sequences and LTR-containing lincRNAs, by blocking their transcription in select cell types[2][6]. U7 snRNA itself is not a receptor, enzyme, or therapeutic target and does not have known interacting drugs[1][7]. However, engineered U7 snRNA scaffolds have been used as delivery systems for antisense oligonucleotides and RNA editing therapeutics in experimental and preclinical settings[4]. Currently, there are no established roles for U7 snRNA as a disease biomarker or therapeutic drug target. There are no notable safety concerns directly associated with endogenous U7 snRNA activity or function[1][4][7].

Other names

U7U7 snRNAU7 small nuclear ribonucleic acidsnRNA U7RNU7-1LOC124903094